Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
Maryka Quik
Based on 15 articles published since 2008
||||
Expertise Level
The expertise of Maryka Quik ranks in the
  • Top 0.3%
  • ... of 69,482 published authors worldwide on Parkinson Disease
  • ... from 2008 through 2019
  • ... based on contributions to 15 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Work Locations
Details
Most likely:    SRI International      
2015
  • Center for Health Sciences, SRI International, Menlo Park, California, USA. Electronic address: · Center for Health Sciences, SRI International, Menlo Park, California, USA. · Pubmed 26472532
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; Department of Neurology, University Hospital Bordeaux, France. · Laboratory of Neurophysiology, Fondazione Santa Lucia, IRCCS, Rome, Italy. · Division of Neuroscience, Institute of Experimental Neurology, San Raffaele Scientific Institute, 20132 Milan, Italy. · Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden. · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Department of Neurology, Columbia University, New York, USA. · Pacific Parkinson's Research Centre and National Parkinson Foundation Centre of Excellence, University of British Columbia, Vancouver, Canada. · Department of Biomedical Sciences, Section of Neuropsychopharmacology, Cagliari University, 09124 Cagliari, Italy. · Univ. de Bordeaux, Institut Interdisciplinaire de neurosciences, UMR 5297, 33000 Bordeaux, France; CNRS, Institut Interdisciplinaire de neurosciences, UMR 5297, 33000 Bordeaux, France. · Department of Neurology, Hospital Universitario Donostia and Neuroscience Unit, Bio Donostia Research Institute, San Sebastian, Spain. · Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Center for Health Sciences, SRI International, CA 94025, USA. · Department of Medical Sciences, Section of Pharmacology, University of Ferrara, Ferrara, Italy. · Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, 20133 Milano, Italy. · Department of Biomedical Sciences, Physiology Section, Cagliari University, Cagliari, Italy. · Motac Neuroscience Ltd, Manchester, UK. · Michigan State University, College of Human Medicine, Department of Translational Science and Molecular Medicine & The Udall Center of Excellence in Parkinson's Disease Research, 333 Bostwick Ave NE, Grand Rapids, MI 49503, USA. · Morton & Gloria Shulman Movement Disorders Center, Toronto Western Hospital, Toronto, Ontario M4T 2S8, Canada. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; Motac Neuroscience Ltd, Manchester, UK. Electronic address: · Pubmed 26209473
  • Center for Health Sciences, SRI International, 333 Ravenswood Ave, CA 94025, USA. Electronic address: · Center for Health Sciences, SRI International, 333 Ravenswood Ave, CA 94025, USA. · Pubmed 26093062
  • The Department of Psychiatry, McGill University, Montréal, Que., Canada. · The Neurodegenerative Diseases Program, Center for Health Sciences, SRI International, Menlo Park, Calif., USA. · The Department of Pharmacology, McGill University, Montréal, Que., Canada. · The Centre for Advanced Research in Environmental Genomics, Department of Biology, University of Ottawa, Ottawa, Ont., Canada. · Pubmed 25903035
2013
  • Center for Health Sciences, SRI International, Menlo Park, California (D.Z., A.M., D.S., M.Q.) · Research Triangle Institute, Research Triangle Park, North Carolina (F.I.C.) · and Targacept, Inc., Winston-Salem, North Carolina (M.B., S.L.). · Pubmed 23902940
  • Center for Health Sciences, SRI International, 333 Ravenswood Ave., Menlo Park, CA 94025, USA. · Pubmed 23583932
2012
  • Center for Health Sciences, SRI International, Menlo Park, California, USA. · Pubmed 22693036
2011
  • Center for Health Sciences, SRI International, Menlo Park, CA 94025, USA. · Pubmed 21969327
  • Center for Health Sciences, SRI International, California 94025, USA. · Pubmed 21838678
  • Center for Health Sciences, SRI International, 333 Ravenswood Avenue, CA 94025, USA. · Pubmed 21684266
2011
  • Center for Health Sciences, SRI International, 333 Ravenswood Ave, CA 94025, USA. · Pubmed 21232546
2010
  • Center for Health Sciences, SRI International, 333 Ravenswood Ave, Menlo Park, California 94025, USA. · Pubmed 20732972
Probable:    Parkinson's Institute      
2009
  • The Parkinson's Institute, Sunnyvale, CA 94085, United States. · Pubmed 19433069
2008
Possible:    Miscellaneous cities in California      
2008
  • The Parkinson's Institute, 675 Almanor Ave., Sunnyvale, CA 94085-2934, USA. · Pubmed 18650244
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 15 total) written by Maryka Quik about Parkinson Disease:

  • Nicotine and Nicotinic Receptor Drugs: Potential for Parkinson's Disease and Drug-Induced Movement Disorders. 2015
  • Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. 2015
  • Alpha7 nicotinic receptors as therapeutic targets for Parkinson's disease. 2015
  • Obituary of Theodore L. Sourkes, PhD, FRSC, OC. 2015
  • Nicotinic receptor agonists reduce L-DOPA-induced dyskinesias in a monkey model of Parkinson's disease. 2013
  • α4β2 Nicotinic receptors play a role in the nAChR-mediated decline in L-dopa-induced dyskinesias in parkinsonian rats. 2013
  • Nicotine as a potential neuroprotective agent for Parkinson's disease. 2012
  • α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease. 2011
  • Targeting nicotinic receptors for Parkinson's disease therapy. 2011
  • Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders. 2011
Show List of Full Article Records
Google Searches

Learn more about Maryka Quik using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
SRI International
Parkinson's Institute
Miscellaneous cities in California
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
SRI International
2015
  • Center for Health Sciences, SRI International, Menlo Park, California, USA. Electronic address: · Center for Health Sciences, SRI International, Menlo Park, California, USA. · Pubmed 26472532
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; Department of Neurology, University Hospital Bordeaux, France. · Laboratory of Neurophysiology, Fondazione Santa Lucia, IRCCS, Rome, Italy. · Division of Neuroscience, Institute of Experimental Neurology, San Raffaele Scientific Institute, 20132 Milan, Italy. · Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden. · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Department of Neurology, Columbia University, New York, USA. · Pacific Parkinson's Research Centre and National Parkinson Foundation Centre of Excellence, University of British Columbia, Vancouver, Canada. · Department of Biomedical Sciences, Section of Neuropsychopharmacology, Cagliari University, 09124 Cagliari, Italy. · Univ. de Bordeaux, Institut Interdisciplinaire de neurosciences, UMR 5297, 33000 Bordeaux, France; CNRS, Institut Interdisciplinaire de neurosciences, UMR 5297, 33000 Bordeaux, France. · Department of Neurology, Hospital Universitario Donostia and Neuroscience Unit, Bio Donostia Research Institute, San Sebastian, Spain. · Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Center for Health Sciences, SRI International, CA 94025, USA. · Department of Medical Sciences, Section of Pharmacology, University of Ferrara, Ferrara, Italy. · Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, 20133 Milano, Italy. · Department of Biomedical Sciences, Physiology Section, Cagliari University, Cagliari, Italy. · Motac Neuroscience Ltd, Manchester, UK. · Michigan State University, College of Human Medicine, Department of Translational Science and Molecular Medicine & The Udall Center of Excellence in Parkinson's Disease Research, 333 Bostwick Ave NE, Grand Rapids, MI 49503, USA. · Morton & Gloria Shulman Movement Disorders Center, Toronto Western Hospital, Toronto, Ontario M4T 2S8, Canada. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; Motac Neuroscience Ltd, Manchester, UK. Electronic address: · Pubmed 26209473
  • Center for Health Sciences, SRI International, 333 Ravenswood Ave, CA 94025, USA. Electronic address: · Center for Health Sciences, SRI International, 333 Ravenswood Ave, CA 94025, USA. · Pubmed 26093062
  • The Department of Psychiatry, McGill University, Montréal, Que., Canada. · The Neurodegenerative Diseases Program, Center for Health Sciences, SRI International, Menlo Park, Calif., USA. · The Department of Pharmacology, McGill University, Montréal, Que., Canada. · The Centre for Advanced Research in Environmental Genomics, Department of Biology, University of Ottawa, Ottawa, Ont., Canada. · Pubmed 25903035
2013
  • Center for Health Sciences, SRI International, Menlo Park, California (D.Z., A.M., D.S., M.Q.) · Research Triangle Institute, Research Triangle Park, North Carolina (F.I.C.) · and Targacept, Inc., Winston-Salem, North Carolina (M.B., S.L.). · Pubmed 23902940
  • Center for Health Sciences, SRI International, 333 Ravenswood Ave., Menlo Park, CA 94025, USA. · Pubmed 23583932
2012
  • Center for Health Sciences, SRI International, Menlo Park, California, USA. · Pubmed 22693036
2011
  • Center for Health Sciences, SRI International, Menlo Park, CA 94025, USA. · Pubmed 21969327
  • Center for Health Sciences, SRI International, California 94025, USA. · Pubmed 21838678
  • Center for Health Sciences, SRI International, 333 Ravenswood Avenue, CA 94025, USA. · Pubmed 21684266
2011
  • Center for Health Sciences, SRI International, 333 Ravenswood Ave, CA 94025, USA. · Pubmed 21232546
2010
  • Center for Health Sciences, SRI International, 333 Ravenswood Ave, Menlo Park, California 94025, USA. · Pubmed 20732972
Parkinson's Institute
2009
  • The Parkinson's Institute, Sunnyvale, CA 94085, United States. · Pubmed 19433069
2008
Miscellaneous cities in California
2008
  • The Parkinson's Institute, 675 Almanor Ave., Sunnyvale, CA 94085-2934, USA. · Pubmed 18650244
Yearly article counts 000040214112
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.